Jiřı́ Mayer

机构：Masaryk University, University Hospital Brno · ORCID：0000-0003-0567-9887

发表论文 1439 篇 · 总被引 29110 次 · h-index 70

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 126)
• Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE (2024 · Blood · 被引 71)
• The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy (2025 · Blood · 被引 57)
• Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study (2024 · British Journal of Haematology · 被引 21)
• Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report (2024 · American Journal of Hematology · 被引 15)
• Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study (2025 · American Journal of Hematology · 被引 14)